| Structure | Chemical Name | CAS | MF |
|
Moxifloxacin-d4
|
|
C21H20FN3O4D4
|
|
Moxifloxacin N-sulfate
|
234080-64-9
|
C21H24FN3O7S
|
|
|
Moxifloxacin acyl glucuronide
|
|
C27H32FN3O10
|
|
|
Moxifloxacin Acyl Sulfate
|
|
C21H24FN3O7S
|
|
MOXIFLOXACIN, HYDROCHLORIDE MONOHYDRATE
|
192927-63-2
|
C21H27ClFN3O5
|
|
Moxifloxacin Acyl-b-D-glucuronide
|
733002-61-4
|
C27H32FN3O10
|
|
|
Moxifensine
|
|
|
|
|
Moxifloxacin for peak identification
|
|
|
|
Moxifloxacin
|
151096-09-2
|
C21H24FN3O4
|
|
Moxifloxacin hydrochloride
|
186826-86-8
|
C21H25ClFN3O4
|
|
|
Moxifloxacin[S,S]-2,8-DiazaBicyclo[4.3.0]Nonane
|
|
|
|
MOXIFLOXACIN
|
158060-78-7
|
C21H24FN3O4
|
|
MPMT
|
845-52-3
|
|
|
Moxilubant
|
146978-48-5
|
C26H37N3O4
|
|
Moxipraquine
|
23790-08-1
|
C24H38N4O2
|
|
Moxiraprine
|
82239-52-9
|
C17H22N4O2
|
|
MOXISYLYTE
|
54-32-0
|
C16H25NO3
|
|
MOXISYLYTE HYDROCHLORIDE
|
964-52-3
|
C16H26ClNO3
|
|
MOXISYLYTE HCL
|
|
C18H30ClNO3
|
|
m-(p-Nitrophenylthio)aniline
|
|
C12H10N2O2S
|
|
|
MoyaoOil
|
|
|
|
|
MPO Assay Buffer
|
|
|
|
|
MPO Chlorination Substrate
|
|
|
|
Moxnidazole
|
52279-59-1
|
C13H18N6O5
|
|
|
MPO DMSO
|
|
|
|
Moxonidine-13CD3
|
|
C9H12ClN5O
|
|
|
MOXONIDINEHCL
|
|
|
|
Moxonidine
|
75438-57-2
|
C9H12ClN5O
|
|
Moxonidine hydrochloride
|
75438-58-3
|
C9H13Cl2N5O
|
|
|
Moxonidine Condensation Compound
|
|
|
|
|
MPO Fluorescein Standard
|
|
|
|
|
Mox-2 protein
|
|
|
|
|
MOX REAGENT
|
|
|
|
|
MPO (human) Control Set
|
|
|
|
|
MPO (human) EIA Standards
|
|
|
|
|
MPO Inhibitor
|
|
|
|
|
MPO Hydrogen Peroxide
|
|
|
|
MPP A
|
6453-67-4
|
C34H36N4O3
|
|
Mozavaptan Hydrochloride
|
138470-70-9
|
C27H29N3O2.ClH
|
|
Mozavaptan
|
137975-06-5
|
C27H29N3O2
|
|
|
MPPE
|
|
|
|
|
moxX protein
|
|
|
|
|
MPO (p-ANCA) ELISA
|
|
|
|
m-[3-[p-(Pentyloxy)phenyl]thioureido]benzenesulfonic acid sodium salt
|
|
C18H21N2NaO4S2
|
|
|
MPO Peroxidation Substrate
|
|
|
|
|
MoxY protein, Aspergillus
|
|
|
|
|
moxY protein
|
|
|
|
|
MP-PERMANGANATE
|
|
|
|
MPPG
|
169209-65-8
|
C9H12NO5P
|
|
|
MPPF, [METHYL-3H]-
|
|
|
|
|
MOZ gene product
|
|
|
|
|
moxZ protein
|
|
|
|
|
MPO Resorufin Standard
|
|
|
|
|
M2, POTASSIUM CYANIDE/PYRIDINE
|
|
|
|
m-(Potassiooxy)benzoic acid potassium salt
|
|
C7H4K2O3
|
|
MPP+ IODIDE
|
36913-39-0
|
C12H12IN
|
|
moyukamycin
|
96827-80-4
|
C47H76O13
|
|
|
MQF-OK-UFT protocol
|
|
|
|
|
MQF-OK protocol
|
|
|
|
|
MQF-OK-FT protocol
|
|
|
|
|
MPP protocol
|
|
|
|
|
MPP3 protein
|
|
|
|
|
MPP11 protein
|
|
|
|
|
Mpp10 protein, fungal
|
|
|
|
|
MP48 protein
|
|
|
|
|
mp41 protein
|
|
|
|
|
MP-1 protein
|
|
|
|
|
MP4 protein
|
|
|
|
|
MP13 protein
|
|
|
|
|
[Mpr105]-ANP (105-126) (rat)
|
|
|
|
|
MprA protein, Burkholderia
|
|
|
|
[MPR7, DALA9] ANP (7-28), AMIDE, RAT
|
|
C107H167N35O32S2
|
|
|
MP regimen
|
|
|
|
|
MOZZARELLA
|
|
|
|
|
MOZZARELLACHEESE
|
|
|
|
|
MP resins
|
|
|
|
|
MPRFMDYWEGLN-K(5/6-TMR)
|
|
|
|
|
mprF protein, Staphylococcus aureus
|
|
|
|
MR 708
|
79380-99-7
|
C11H13NO3.C10H17N
|
|
MR 897
|
87549-36-8
|
C17H15NO5
|
|
MR 356
|
120146-92-1
|
C23H38O7
|
|
MR 121
|
185308-24-1
|
C24H28N3O3+
|
|
|
M 13 PRIMER P7
|
|
|
|
|
M 13 PRIMER P2
|
|
|
|
|
M 13 PRIMER P5(REVERSE)
|
|
|
|
|
M 13 PRIMER P8(REVERSE)
|
|
|
|
|
M 13 PRIMER P6(HYBRIDIZATION)
|
|
|
|
|
MpsA protein
|
|
|
|
|
M-PRM
|
|
|
|
|
MP200 RNA
|
|
|
|
|
M13 procoat protein
|
|
|
|
m-(propionamido)anilinodiethyl diacetate
|
24311-37-3
|
C17H24N2O5
|
|
3-(m-Propylphenoxy)-1,2-propanediol
|
63991-77-5
|
C12H18O3
|
|
|
m4 protein
|
|
|
|
M PROTEIN EPITOPE OF GROUP A STREPTOCOCCI
|
152044-86-5
|
C99H175N33O33
|
|
|
M83 protein
|
|
|
|
|
M PROTEIN TYROSINE PHOSPHATASE
|
|
|
|
|
M PROTEIN TYROSINE PHOSPHATASE, AGAROSE
|
|
|
|
|
M5 proteinase
|
|
|
|
|
M31 protein, mammal
|
|
|